WHO Approves Viral Load Test, Boosting Uganda's HIV/Aids Fight
Uganda has partnered with U.S. based company Abbott to deploy different diagnostic tools. Among them is the m-PIMA HIV-1/2 VL, a portable molecular point-of-care viral load diagnostic test that officials in Uganda say will make the objective to end HIV/Aids by 2030 easier to achieve.
Blood samples to test viral load (file photo).
-
Uganda:
Stigma to Blame for High HIV/Aids Deaths
Monitor, 17 May 2019
The continued stigma against people living with HIV/aids is responsible for high numbers of the scourge-related deaths despite the introduction of antiretroviral therapy drugs that… Read more »
-
Uganda:
HIV Infection Rate in Lira Drops
Monitor, 7 May 2019
The HIV infection rate in Lira District has dropped by 1.8 per cent between 2014 and 2019, from 8.9 per cent to 7.1 per cent, according to new estimates from the district health… Read more »
InFocus
-
Various HIV/Aids service providers are operating in isolation which sometimes leads to patients visiting more than one health center for the same service. Health authorities are ... Read more »